DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Lentz SR, Misgav M, Ozelo M. et al.
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy.
Haemophilia 2013;
19 (05) 691-697
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.